Top news of the week: 13.10.2021.
Companies And Industries
AI Tool Named Higashi Sweetens Analysis of Single-Cell Hi-C Data
A new algorithm, named Higashi, used in conjunction with single cell Hi-C, provides a high-definition analysis of genome organization in single cells.
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program
CureVac giving up on first COVID mRNA vax, focusing on GSK-partnered 2nd attempt
With more than a touch of inevitability, CureVac is abandoning its first mRNA COVID vaccine after dismal results earlier this year, and switching focus to its second mRNA asset with ...
GENLive GEN 40th Anniversary: Getting the Band Back Together
Reflecting on Biotech’s Baby Steps and its March to Maturity. In celebration of GEN’s 40th year in publishing, GEN Live will feature a panel of biotech reporters and scientists who have ...
Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space
Patients and patient organizations, which have detailed insights in the natural history of a rare disease, should be integral, too.
Late in the Game, CureVac Lays Down COVID Vaccine for a Better Hand
Teamed up with pharma giant GlaxoSmithKline, CureVac is now focusing on a more promising target – second-generation mRNA vaccines.
Ginkgo Bioworks Hit After Short Seller Claims Business Model a 'Shell Game'
Litigator Block & Leviton is launching an investigation into Ginkgo Bioworks after short seller Scorpion Capital released a report alleging that Ginkgo is running a fraudulent operation.
Dr. Gottlieb sees Covid’s ‘pandemic phase’ ending when antiviral pills, kids’ vaccines available
The former FDA chief and current Pfizer board member believes vaccines for kids and oral antiviral drugs will be "very important psychological events."